抑制PTPN3有助于激活树突细胞功能,成为一个有前途的新免疫疗法点
相关实验视频
Updated: Jul 19, 2025
12:08
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
Published on: May 17, 2019
9.3K
Naoya Iwamoto1, Hideya Onishi2, Shogo Masuda1
1Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan.
Journal of cancer research and clinical oncology
|August 16, 2023
概括
抑制蛋白氨酸酸酶非受体3型 (PTPN3) 增强树突细胞 (DC) 功能,促进抗癌免疫反应. 这一发现支持PTPN3作为新型癌症免疫疗法的标,激活淋巴细胞和DCs.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 细胞生物学 细胞生物学
背景情况:
- 蛋白氨酸酸酶非受体3型 (PTPN3) 之前被确定为淋巴细胞中的免疫检查点分子.
- PTPN3在树突细胞 (DC) 功能中的作用,对于免疫疗法开发至关重要,在很大程度上仍未被探索.
研究的目的:
- 研究PTPN3对人类外周血液单细胞衍生的树突细胞 (DCs) 的生物学影响.
- 评估针对PTPN3的潜力,以增强DC介导的抗癌免疫力.
主要方法:
- 短干扰RNA (siRNA) 用于在DC中击倒PTPN3表达.
- 使用癌细胞溶解酸和TNF-α/IFN-α来诱导DC成熟.
- 用匹配和不匹配的癌症细胞系进行了细胞毒性测试.
- 通过ELISA和细胞内染色分析了细胞因子的产生和细胞内信号通路.
主要成果:
- 抑制PTPN3显著增加了DC数,CD80和CCR7的表达,以及IL-12的产生.
- 在成熟的DC中抑制PTPN3增强了细胞毒性T淋巴细胞诱导,INF-γ和B粒酶的产生,以及抗癌细胞毒性.
- 抑制PTPN3促进了DC向癌细胞的迁移,并激活了MAPK信号通路.
结论:
- 抑制PTPN3可以增强DC成熟,功能和抗瘤活性.
- 向PTPN3代表了开发新型癌症免疫疗法,激活DC和淋巴细胞的有希望的战略.
相关概念视频
01:27Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
01:22T Cell Activation and Clonal Selection
808
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
808